Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Sanofi SA

SNY ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Large Cap Analyst: BUY

Last Close

$43.72

▼ -0.14%

Market Cap $105.14B · Vol 868.56K

Key Metrics

P/E Ratio

23.29

FWD: 8.38

Market Cap

$105.14B

Large Cap

Div Yield

5.46%

Annual dividend

EPS Growth

+11.68%

YoY

RSI (14)

47.64

Momentum

Beta

0.32

vs Market

52W High

$52.68

17.01% below

52W Low

$40.89

6.92% above

Volume

868.56K

Avg 829.56K

P/B

1.40

Price-to-book

ROE

12.84%

Return on equity

Free Float

100.00%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Sanofi SA (SNY) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does SNY pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.60%

+1.25%

+2.03%

-4.98%

YTD

-9.78%

-10.85%

-17.20%

-15.08%

Financials & Valuation

TTM · Annual

Total Revenue	$54.87B
Net Income	$6.03B
Revenue Growth (YoY)	+17.95%
Gross Margin	68.27%
Operating Margin	20.81%
Net Profit Margin	10.65%
ROE	12.84%
ROA · ROIC	4.76% · 8.96%

P/E Ratio	23.29
Forward P/E (FY1)	8.38
PEG Ratio	0.27
P/S	2.26
P/B	1.40
P/FCF	10.45
EPS Growth	+11.68%
Outstanding Shares	1.21B

Technical Indicators

50-Day SMA	$43.40
200-Day SMA	$46.17
RSI (14)	47.64
Beta	0.32
52-Week High	$52.68
52-Week Low	$40.89

Volume Today	868.56K
Avg Daily Volume (30D)	829.56K
Relative Volume	1.05x
Volatility (10D)	7.64
Volatility (30D)	22.63
Free Float	100.00%

Analyst Consensus

BUY

Current Price $43.72

Mean Target $54.73

52W Low$40.89 52W High$52.68

Current

Target

$40.89 $52.68

Current Analyst target

+25.18% upside potential · 8 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001S5W768

ISINUS80105N1054

CountryFrance

Sub-IndustryPharmaceuticals (NEC)

Earnings DateOct 28, 2026

TypeStocks

Instrument TypeADR American Depositary Receipt

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.